Reported in roughly 5% of trial participants
Other participants in the Health Connect South panel discussion were David Bardan, General Manager and Head of Healthcare for CLEAR, and Dr
Boxed Warning The FDAs Boxed Warning for Xarelto includes: Stopping Xarelto too soon may increase risk of blood clots Risk of spinal/epidural hematomas with spinal procedures, which may cause paralysis Notify your provider of any symptoms like numbness, tingling, or bowel/bladder problems if you have had spinal anesthesia or puncture
It may help reduce the appearance of dullness, dark spots, uneven tone, and dryness when used consistently
The SURMOUNT trial series showed that tirzepatide consistently outperformed semaglutide when both were studied head-to-head in similar patient populations
The PEACE 5 and PANTHEON 6 studies have shown that the longer the treatment duration, the better is the outcome that the patients would have